Auxilium Buys Actient As Base Business Weakens
This article was originally published in The Pink Sheet Daily
Executive Summary
The acquisition will establish Auxilium as a leading urology company and add nine commercial products. But the $585 million upfront acquisition price is expensive for Auxilium, as sales of its own products slump.